Advertisement

Topics

An experimental drug from Cytokinetics failed to improve the lung function of patients with ALS compared to a placebo, but CEO Robert Blum says the company still intends to move to Phase 3 clinical trial. https://buff.ly/2E0MGGk 

13:00 EDT 11 May 2019 | STAT

An experimental drug from Cytokinetics failed to improve the lung function of patients with ALS compared to a placebo, but CEO Robert Blum says the company still intends to move to Phase 3 clinical trial. https://buff.ly/2E0MGGk 

Original Article: An experimental drug from Cytokinetics failed to improve the lung function of patients with ALS compared to a placebo, but CEO Robert Blum says the company still intends to move to Phase 3 clinical trial. https://buff.ly/2E0MGGk 

NEXT ARTICLE

More From BioPortfolio on "An experimental drug from Cytokinetics failed to improve the lung function of patients with ALS compared to a placebo, but CEO Robert Blum says the company still intends to move to Phase 3 clinical trial. https://buff.ly/2E0MGGk "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...